WO2011070057A1 - Produits nutritionnels comprenant des céréales entières hydrolysées - Google Patents
Produits nutritionnels comprenant des céréales entières hydrolysées Download PDFInfo
- Publication number
- WO2011070057A1 WO2011070057A1 PCT/EP2010/069147 EP2010069147W WO2011070057A1 WO 2011070057 A1 WO2011070057 A1 WO 2011070057A1 EP 2010069147 W EP2010069147 W EP 2010069147W WO 2011070057 A1 WO2011070057 A1 WO 2011070057A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- whole grain
- nutritional product
- vitamin
- product according
- composition
- Prior art date
Links
- 235000020985 whole grains Nutrition 0.000 title claims abstract description 167
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 123
- 239000000203 mixture Substances 0.000 claims abstract description 102
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 51
- 102000004139 alpha-Amylases Human genes 0.000 claims abstract description 36
- 108090000637 alpha-Amylases Proteins 0.000 claims abstract description 36
- 229940024171 alpha-amylase Drugs 0.000 claims abstract description 31
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 30
- 229940088594 vitamin Drugs 0.000 claims abstract description 26
- 229930003231 vitamin Natural products 0.000 claims abstract description 26
- 235000013343 vitamin Nutrition 0.000 claims abstract description 26
- 239000011782 vitamin Substances 0.000 claims abstract description 26
- 239000012634 fragment Substances 0.000 claims abstract description 23
- 235000021321 essential mineral Nutrition 0.000 claims abstract description 13
- 239000000047 product Substances 0.000 claims description 159
- 102000004190 Enzymes Human genes 0.000 claims description 95
- 108090000790 Enzymes Proteins 0.000 claims description 95
- 229940088598 enzyme Drugs 0.000 claims description 95
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 34
- 108091005804 Peptidases Proteins 0.000 claims description 32
- 239000008103 glucose Substances 0.000 claims description 32
- 239000004365 Protease Substances 0.000 claims description 29
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 20
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical group OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 16
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 15
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 15
- 238000004519 manufacturing process Methods 0.000 claims description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 11
- 108700040099 Xylose isomerases Proteins 0.000 claims description 11
- -1 preferably Chemical compound 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 10
- 108010019077 beta-Amylase Proteins 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 235000019155 vitamin A Nutrition 0.000 claims description 6
- 239000011719 vitamin A Substances 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 229930003779 Vitamin B12 Natural products 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 239000011575 calcium Substances 0.000 claims description 5
- 229960000304 folic acid Drugs 0.000 claims description 5
- 235000019152 folic acid Nutrition 0.000 claims description 5
- 239000011724 folic acid Substances 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 235000019192 riboflavin Nutrition 0.000 claims description 5
- 239000002151 riboflavin Substances 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 235000019157 thiamine Nutrition 0.000 claims description 5
- 239000011721 thiamine Substances 0.000 claims description 5
- 235000019163 vitamin B12 Nutrition 0.000 claims description 5
- 239000011715 vitamin B12 Substances 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- 230000000415 inactivating effect Effects 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 235000011962 puddings Nutrition 0.000 claims description 3
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 2
- 229930003448 Vitamin K Natural products 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 229910052796 boron Inorganic materials 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- 239000011651 chromium Substances 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 229910052750 molybdenum Inorganic materials 0.000 claims description 2
- 239000011733 molybdenum Substances 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011669 selenium Substances 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 229910052710 silicon Inorganic materials 0.000 claims description 2
- 239000010703 silicon Substances 0.000 claims description 2
- 239000012265 solid product Substances 0.000 claims description 2
- 229910052718 tin Inorganic materials 0.000 claims description 2
- 239000011135 tin Substances 0.000 claims description 2
- 229910052720 vanadium Inorganic materials 0.000 claims description 2
- 235000019168 vitamin K Nutrition 0.000 claims description 2
- 239000011712 vitamin K Substances 0.000 claims description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 2
- 229940046010 vitamin k Drugs 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 2
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 claims 1
- 235000000346 sugar Nutrition 0.000 description 34
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 32
- 102000035195 Peptidases Human genes 0.000 description 29
- 239000000835 fiber Substances 0.000 description 29
- 235000013339 cereals Nutrition 0.000 description 22
- 229920002498 Beta-glucan Polymers 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 235000007319 Avena orientalis Nutrition 0.000 description 16
- 241000209140 Triticum Species 0.000 description 16
- 235000021307 Triticum Nutrition 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 229920000617 arabinoxylan Polymers 0.000 description 15
- 235000018102 proteins Nutrition 0.000 description 15
- 229930006000 Sucrose Natural products 0.000 description 14
- 239000005720 sucrose Substances 0.000 description 14
- 108010056079 Subtilisins Proteins 0.000 description 13
- 102000005158 Subtilisins Human genes 0.000 description 13
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 13
- 230000015556 catabolic process Effects 0.000 description 13
- 239000012467 final product Substances 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- 229930091371 Fructose Natural products 0.000 description 11
- 239000005715 Fructose Substances 0.000 description 11
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 11
- 238000006731 degradation reaction Methods 0.000 description 11
- 235000013305 food Nutrition 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- 244000075850 Avena orientalis Species 0.000 description 10
- 235000007558 Avena sp Nutrition 0.000 description 10
- 240000005979 Hordeum vulgare Species 0.000 description 10
- 235000007340 Hordeum vulgare Nutrition 0.000 description 10
- 229920002472 Starch Polymers 0.000 description 10
- 230000002255 enzymatic effect Effects 0.000 description 10
- 235000003599 food sweetener Nutrition 0.000 description 10
- 238000011534 incubation Methods 0.000 description 10
- 238000001542 size-exclusion chromatography Methods 0.000 description 10
- 235000019698 starch Nutrition 0.000 description 10
- 239000003765 sweetening agent Substances 0.000 description 10
- 102000013142 Amylases Human genes 0.000 description 9
- 108010065511 Amylases Proteins 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- 150000001720 carbohydrates Chemical class 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 8
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 235000010755 mineral Nutrition 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 241000209761 Avena Species 0.000 description 6
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 6
- 235000019418 amylase Nutrition 0.000 description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 6
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 6
- 235000013312 flour Nutrition 0.000 description 6
- 239000000413 hydrolysate Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 4
- 241000219051 Fagopyrum Species 0.000 description 4
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 4
- 244000062793 Sorghum vulgare Species 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 229930182830 galactose Natural products 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 125000003071 maltose group Chemical group 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 235000011875 whole grain product Nutrition 0.000 description 4
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 3
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 241000209504 Poaceae Species 0.000 description 3
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 150000004804 polysaccharides Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 240000001592 Amaranthus caudatus Species 0.000 description 2
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 240000006162 Chenopodium quinoa Species 0.000 description 2
- 240000007154 Coffea arabica Species 0.000 description 2
- 244000077995 Coix lacryma jobi Species 0.000 description 2
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 2
- 241000371652 Curvularia clavata Species 0.000 description 2
- 240000008570 Digitaria exilis Species 0.000 description 2
- 235000014966 Eragrostis abyssinica Nutrition 0.000 description 2
- 244000140063 Eragrostis abyssinica Species 0.000 description 2
- 244000130270 Fagopyrum tataricum Species 0.000 description 2
- 235000019715 Fonio Nutrition 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000745991 Phalaris Species 0.000 description 2
- 235000005632 Phalaris canariensis Nutrition 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 229920000294 Resistant starch Polymers 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 244000082988 Secale cereale Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 235000019714 Triticale Nutrition 0.000 description 2
- 240000003834 Triticum spelta Species 0.000 description 2
- 235000004240 Triticum spelta Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 241000746966 Zizania Species 0.000 description 2
- 235000002636 Zizania aquatica Nutrition 0.000 description 2
- 239000004178 amaranth Substances 0.000 description 2
- 235000012735 amaranth Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940025131 amylases Drugs 0.000 description 2
- 239000008122 artificial sweetener Substances 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 239000004464 cereal grain Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000016213 coffee Nutrition 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 150000004676 glycans Polymers 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 150000004682 monohydrates Chemical class 0.000 description 2
- 150000002772 monosaccharides Chemical group 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000021254 resistant starch Nutrition 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 238000007669 thermal treatment Methods 0.000 description 2
- 235000021126 varied diet Nutrition 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 241000228158 x Triticosecale Species 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 208000004611 Abdominal Obesity Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 229930188104 Alkylresorcinol Natural products 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108010073032 Grain Proteins Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 1
- 102000001746 Pancreatic alpha-Amylases Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 238000010793 Steam injection (oil industry) Methods 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- 150000004783 arabinoxylans Chemical class 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000020979 dietary recommendations Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009837 dry grinding Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000019534 high fructose corn syrup Nutrition 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000021097 low calorie intake Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000013365 molecular weight analysis method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 210000001819 pancreatic juice Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000021580 ready-to-drink beverage Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 235000011844 whole wheat flour Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
- A23L7/107—Addition or treatment with enzymes not combined with fermentation with microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/117—Flakes or other shapes of ready-to-eat type; Semi-finished or partly-finished products therefor
- A23L7/126—Snacks or the like obtained by binding, shaping or compacting together cereal grains or cereal pieces, e.g. cereal bars
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/161—Puffed cereals, e.g. popcorn or puffed rice
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/197—Treatment of whole grains not provided for in groups A23L7/117 - A23L7/196
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/10—Coating with edible coatings, e.g. with oils or fats
- A23P20/12—Apparatus or processes for applying powders or particles to foodstuffs, e.g. for breading; Such apparatus combined with means for pre-moistening or battering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01001—Alpha-amylase (3.2.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01033—Amylo-alpha-1,6-glucosidase (3.2.1.33)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
Definitions
- Nutritional products comprising hydrolyzed whole grain
- the present invention relates to nutritional products being supplemented with whole grain.
- the present invention relates to nutritional products which are supplemented with hydrolysed whole grain, where neither taste or viscosity nor organoleptic properties of the nutritional product have been compromised.
- Whole grains are also a recognised source of dietary fibers, phytonutrients, antioxidants, vitamins and minerals. According to the definition given by the American Association of Cereal Chemists (AACC), whole grains, and food made from whole grains, consist of the entire grain seed.
- the entire grain seed comprises the germ, the endosperm and the bran. It is usually referred to as the kernel.
- Another difficulty in just increasing the whole grain content of the product is that it usually impacts on physical properties such as the taste, texture and the overall appearance of the nutritional product (organoleptic parameters), as well as its processability.
- organoleptic parameters the overall appearance of the nutritional product
- the consumer is not willing to compromise on nutritional products organoleptic properties, in order to increase his daily whole grain intake.
- Taste, texture and overall appearance are such organoleptic properties.
- US 4,282,319 relates to a process for the preparation of hydrolyzed products from whole grain, and such derived products.
- the process includes an enzymatic treatment in an aqueous medium with a protease and an amylase.
- the obtained product may be added to different types of products.
- US 4,282,319 describe a complete degradation of the proteins present in the whole grain.
- US 5,686,123 discloses a cereal suspension generated by treatment with both an alpha-amylase and a beta-amylase both specifically generating maltose units and have no glucanase effect.
- the invention relates to a nutritional product comprising
- alpha-amylase or fragment thereof which alpha-amylase or fragment thereof shows no hydrolytic activity towards dietary fibers when in the active state; wherein said nutritional product is fortified with at least 2 essential minerals and at least 4 essential vitamins.
- Another aspect of the present invention relates to a process for preparing a nutritional product, said process comprising :
- preparing a hydrolyzed whole grain composition comprising the steps of: a) contacting a whole grain component with an enzyme composition in water, the enzyme composition comprising at least one alpha-amylase, said enzyme composition showing no hydrolytic activity towards dietary fibers, b) allowing the enzyme composition to react with the whole grain
- Figure 1 shows a thin layer chromatography analysis of various enzymes put in contact with dietary fibres.
- the legend for the different tracks is the following : AO : pure arabinoxylan spot (blank)
- Figure 2 shows size exclusion chromatography (SEC) of ⁇ -Glucan
- arabinoxylan molecular weight profile without enzyme addition (plain line) and after incubation with Alcalase 2.4L (dotted line).
- Figure 3 shows size exclusion chromatography (SEC) of ⁇ -Glucan
- the inventors of the present invention have surprisingly found that by treating the whole grain component with an alpha-amylase and optionally with a protease the whole grain will become less viscous and the following mixing into the nutritional product may be easier. This results in the possibility to increase the amount of whole grains in the product. Furthermore, the alpha-amylase treatment also results in a reduced need for adding sweetener such as sucrose to the nutritional products.
- the invention relates to a nutritional product comprising - a hydrolyzed whole grain composition
- alpha-amylase or fragment thereof which alpha-amylase or fragment thereof shows no hydrolytic activity towards dietary fibers when in the active state; wherein said nutritional product is fortified with at least 2 essential minerals and at least 4 essential vitamins.
- An additional advantage may be to improve the carbohydrate profile of the nutritional product products by replacing traditional externally supplied sweeteners such as glucose syrup, high fructose corn syrup, invert syrup, maltodextrine, sucrose, fiber concentrate, inulin, etc. with a more wholesome sweetener source.
- the term "nutritional product” relates to a packaged products in a prepared form, such as a liquid or pudding that are ready for consumption or as a product which are to be reconstituted in a liquid before consumption such as a powder.
- a liquid or pudding that are ready for consumption or as a product which are to be reconstituted in a liquid before consumption such as a powder.
- ready for consumption is meant that the product is ready and suitable to be consumed directly from the package without the need for the addition of further ingredients.
- the term “ready for consumption” does not exclude pouring the product or part of the product into a glass, cup, jar or the like.
- the nutritional product is a powder, a semi-solid product such as a pudding or a liquid.
- the nutritional product is to be reconstituted in a liquid component before consumption.
- the present invention comprises at least 2 essential minerals and at least 4 essential vitamins.
- Minerals are components of foods that are involved in many body functions. For example, calcium and magnesium are important for bone structure, and iron is needed for our red blood cells to transport oxygen. Like vitamins, minerals are not a source of energy and are best obtained through a varied diet rather than supplements.
- the nutritional product according to the invention may be fortified with minerals and vitamins.
- the nutritional product comprises at least two essential minerals, such as at least 4, such as at least 6, and such as at least 8 essential minerals.
- the essential minerals are selected from the group consisting of calcium, copper, iodine, iron, magnesium, manganese, phosphorus, boron, chromium, molybdenum, nickel, potassium, selenium, silicon, tin, and vanadium, preferably, zinc, calcium, magnesium and any combination thereof.
- Vitamins are compounds that help to regulate chemical reactions in the body. There are 13 vitamins, including vitamins A, B complex, C, D, E, and K. Because most vitamins cannot be made in the body, we must obtain them through the diet. Many people say that they feel more energetic after consuming vitamins, but vitamins are not a source of energy (calories). Vitamins are best consumed through a varied diet rather than as a supplement because there is little chance of taking too high a dose.
- the nutritional product may comprises at least 4 essential vitamins, such as at least 6, such as at least 8, and such as at least 10 essential vitamins.
- the essential vitamins are selected from the group consisting of biotin, folic acid, niacin, pantothenic acid, riboflavin, thiamin, vitamin A, vitamin B12, vitamin B6, vitamin C, vitamin D, vitamin E and vitamin K, in particular folic acid, riboflavin, thiamin, vitamin A, vitamin B12, vitamin B6, vitamin C, vitamin D, vitamin E and any combination thereof.
- the vitamins are selected from the group consisting of Folic Acid, Riboflavin, Thiamin, Vitamin A, Vitamin B6, Vitamin B12, Vitamin C, Vitamin D, Vitamin E, and any combination thereof.
- Providing amounts may be arbitrary and are generally referred to by serving because, many products may be designed for sole nutrition and would therefore have an amount that would be dangerous if not life threatening if put into a product which is not intended as a sole source of nutrition or useless in the reverse.
- the ranges provided in the table below covers the interval Lower
- Reference Nutrient Intake preferably meant to include the lower end of physiological needs, or defined as the average minus 2 standard deviation, and up to the Tolerable Upper Limit (maximum nutrient level that will likely pose no risk of adverse events) both of which are known to a person of ordinary skill in the art).
- Serving size vary as well from elderly product designed to provide substantial nutrition during med pass (when they take their meds) (typically 60-125ml) to about 237ml for a typical Boost product to 1.5L for tube feeding .
- Amount of vitamin and mineral in a product per serving :
- viscosity is a measurement of "thickness” or fluidability of a fluid .
- viscosity is a measure of the resistance of a fluid which is being deformed by either shear stress or tensile stress. If not indicated otherwise viscosity is given in mPa.s.
- Viscosity may be measured using a Rapid Visco Analyser from Newport Scientific.
- the Rapid Visco Analyser measures the resistance of the product to the stirring action of a paddle. The viscosity is measured after 10 minutes stirring, at 65°C and 50 rpm.
- the viscosity of the nutritional product according to the invention may vary depending on the specific products.
- the nutritional product is a liquid having a viscosity is in the range 1-300 mPa.s, such as in the range 10-200 mPa.s, such as in the range 10-150 mPa.s, such as in the range 10-100 mPa.s, such as in the range 10-50 mPa.s, such as in the range 2-50 mPa.s, or such as in the range 2-20 mPa.s.
- the whole grain component may be obtained from different sources.
- whole grain sources are semolina, cones, grits, flour and micronized grain
- the whole grains may be grounded, preferably by dry milling . Such grounding may take place before or after the whole grain component being contacted with the enzyme composition according to the invention.
- the whole grain component may be heat treated to limit rancidity and microbial count.
- Whole grains are cereals of monocotyledonous plants of the Poaceae family (grass family) cultivated for their edible, starchy grains. Examples of whole grain cereals include barley, rice, black rice, brown rice, wild rice, buckwheat, bulgur, corn, millet, oat, sorghum, spelt, triticale, rye, wheat, wheat berries, teff, canary grass, Job's tears and fonio. Plant species that do not belong to the grass family also produce starchy seeds or fruits that may be used in the same way as cereal grains, are called pseudo-cereals.
- pseudo-cereals examples include amaranth, buckwheat, tartar buckwheat and quinoa. When designating cereals, this will include both cereal and pseudo-cereals. Thus, the whole grain component according to the invention may originate from a cereal or a pseudo-cereal.
- the hydrolyzed whole grain composition is obtained from a plant selected from the group consisting of barley, rice, brown rice, wild rice, black rice, buckwheat, bulgur, corn, millet, oat, sorghum, spelt, triticale, rye, wheat, wheat berries, teff, canary grass, Job's tears, fonio, amaranth, buckwheat, tartar buckwheat, quinoa, other variety of cereals and pseudo-cereals and mixtures thereof.
- the source of grain depends on the product type, since each grain will provide its own taste profile.
- Whole grain components are components made from unrefined cereal grains.
- Whole grain components comprise the entire edible parts of a grain; i.e. the germ, the endosperm and the bran.
- Whole grain components may be provided in a variety of forms such as ground, flaked, cracked or other forms, as is commonly known in the milling industry.
- the phrasing "a hydrolyzed whole grain composition" refers to enzymatically digested whole grain components or a whole grain component digested by using at least an alpha-amylase, which alpha-amylase shows no hydrolytic activity towards dietary fibers when in the active state.
- the hydrolyzed whole grain composition may be further digested by the use of a protease, which protease shows no hydrolytic activity towards dietary fibers when in the active state.
- a hydrolyzed whole grain composition is also relating to enzymatic treatment of flour and subsequent reconstitution of the whole grain by blending flour, bran and germ. It is also to be understood that reconstitution may be done before the use in the final product or during mixing in a final product. Thus, reconstitution of whole grains after treatment of one or more of the individual parts of the whole grain also forms part of the present invention.
- the whole grain component Prior to or after grinding of the whole grain, the whole grain component may be subjected to a hydrolytic treatment in order to breakdown the polysaccharide structure and optionally the protein structure of the whole grain component.
- the hydrolyzed whole grain composition may be provided in the form of a liquid, a concentrate, a powder, a juice or a puree. If more than one type of enzymes is used it is to be understood that the enzymatic processing of the whole grains may be performed by sequential addition of the enzymes, or by providing an enzyme composition comprising more than one type of enzyme.
- an enzyme showing no hydrolytic activity towards dietary fibers when in the active state should be understood as also encompassing the enzyme mixture from which the enzyme originates.
- the proteases, amylases, glucose isomerase and amyloglucosidase described in the present context may be provided as an enzyme mixture before use which is not completely purified and thus, comprise enzymatic activity towards e.g. dietary fibers.
- the activity towards dietary fibers may also come from the specific enzyme if the enzyme is multi-functional.
- the enzymes (or enzyme mixtures) are devoid of hydrolytic activity towards dietary fibers.
- no hydrolytic activity or “devoid of hydrolytic activity towards dietary fibers” may encompass up to 5% degradation of the dietary fibers, such as up to 3%, such as up to 2% and such as up to 1% degradation. Such degradation may be unavoidable if high concentrations or extensive incubation times are used .
- In the active state refers to the capability of the enzyme or enzyme mixture to perform hydrolytic activity, and is the state of the enzyme before it is inactivated . Inactivation may occur both by degradation and denaturation.
- the nutritional product according to the invention may comprise a protease which shows no hydrolytic activity towards dietary fibers when in the active state.
- the advantage of adding a protease according to the invention is that the viscosity of the hydrolyzed whole grain may be further lowered, which may also result in a decrease in the viscosity of the final product.
- the nutritional product comprises said protease or fragment thereof at a concentration of 0.0001 to 5% (w/w) by weight of the total whole grain content, such as 0.01-3%, such as 0.01-1%, such as 0.05-1%, such as 0.1- 1%, such as 0.1-0.7%, or such as 0.1-0.5%.
- the optimal concentration of added proteases depends on several factors.
- protease may be considered as a tradeoff between lower viscosity and off-taste.
- amount of protease may also depend on the incubation time during production of the hydrolyzed whole grain. For example a lower concentration of protease may be used if the incubation time is increased.
- Proteases are enzymes allowing the hydrolysis of proteins. They may be used to decrease the viscosity of the hydrolyzed whole grain composition . Alcalase 2.4L (EC 3.4.21.62), from Novozymes is an example of a suitable enzyme.
- a certain amount of the proteins from the hydrolyzed whole grain component may be hydrolyzed to amino acid and peptide fragments.
- 1-10% of the proteins from the whole grain composition is hydrolyzed, such as 2-8%, e.g . 3-6%, 10- 99%, such as 30-99%, such as 40-99%, such as 50-99%, such as 60-99%, such as 70-99%, such as 80-99%, such as 90-99%, or such as 10-40%, 40-70%, and 60-99%.
- protein degradation may result in a lowered viscosity and improved organoleptic parameters.
- hydrolyzed protein content refers to the content of hydrolyzed protein from the whole grain composition unless otherwise defined .
- the protein may be degraded into larger or smaller peptide units or even into amino acid components.
- the person skilled in the art will know that during processing and storage small amount of degradation will take place which is not due to external enzymatic degradation.
- the enzymes used in the production of the hydrolyzed whole grain composition (and therefore also present in the final product) is different from the corresponding enzymes naturally present in the whole grain component.
- the nutritional product according to the invention may also comprise proteins from sources, different from the hydrolyzed whole grain component, which are not degraded, it may be appropriate to evaluate the protein degradation on more specific proteins present in the whole grain composition .
- the degraded proteins are whole grain proteins, such as gluten proteins, globulins, albumins and glycoproteins.
- Amylase (EC 3. 2. 1. 1) is an enzyme classified as a saccharidase : an enzyme that cleaves polysaccharides. It is mainly a constituent of pancreatic juice and saliva, needed for the breakdown of long-chain carbohydrates such as starch, into smaller units.
- alpha-amylase is used to hydrolyse gelatinized starch in order to decrease the viscosity of the hydrolyzed whole grain composition.
- Validase HT 425L, Validase RA from Valley Research, Fungamyl from Novozymes and MATS from DSM are examples of alpha-amylases suitable for the present invention. Those enzymes show no activity towards the dietary fibers in the processing conditions used (duration, enzyme concentrations) . On the contrary, e.g . BAN from Novozymes degrades dietary fibers besides starch into low molecular weight fibers or oligosaccharides, see also example 3.
- the enzymes show no activity towards the dietary fibers when the enzyme concentration is below 5% (w/w), such as below, 3% (w/w), e.g . below 1% (w/w), such as below 0.75% (w/w), e.g . below 0.5% (w/w) .
- alpha-amylases generate maltose units as the smallest carbohydrate entities, whereas others are also able to produce a fraction of glucose units.
- the alpha-amylase or fragments thereof is a mixed sugar producing alpha-amylase, including glucose producing activity, when in the active state. It has been found that some alpha-amylases both comprise glucose producing activity while having no hydrolytic activity towards dietary fibers when in the active state. By having an alpha-amylase which comprises glucose producing activity an increased sweetness may be obtained, since glucose has almost twice the sweetness of maltose.
- a reduced amount of external sugar source needs to be added separately to the nutritional product when a hydrolysed whole grain composition according to the present invention is used .
- an alpha-amylase comprising glucose producing activity When used in the enzyme composition, it may become possible to dispense or at least reduce the use of other external sugar sources or non-sugar sweeteners.
- the term "external sugar or non-sugar sweetener source” relates to sugars and non-sugar sweeteners not originally present or originally generated in the hydrolysed whole grain composition. Examples of such external sugar or non-sugar sources could be sucrose, lactose, and artificial sweeteners.
- Amyloglucosidase (EC 3.2.1.3) is an enzyme able to release glucose residues from starch, maltodextrins and maltose by hydrolyzing glucose units from the non- reduced end of the polysaccharide chain.
- the nutritional product further comprises an amyloglucosidase or fragments thereof. It may be advantageous to add an amyloglucosidase to the production of the hydrolyzed whole grain composition, since the sweetness of the preparation increases with the increasing concentration of released glucose. It may also be advantageous if the amyloglucosidase did not influence health properties of the whole grains, directly or indirectly. Thus, in an embodiment the amyloglucosidase shows no hydrolytic activity towards dietary fibers when in the active state.
- An interest of the invention, and particularly of the process for preparing the nutritional product according to the invention is that it allows reducing the sugar (e.g. sucrose) content of the nutritional product when compared to products described in the prior art. When an amyloglucosidase is used in the enzyme composition, it may become possible to dispense with other external sugar sources e.g. the addition of sucrose.
- the nutritional product according to the invention does not comprise an
- amyloglucosidase such as an exogenic amyloglucosidase.
- Glucose isomerase D-glucose ketoisomerase causes the isomerization of glucose to fructose.
- the nutritional product further comprises a glucose isomerase or fragments thereof, which glucose isomerase or fragments thereof show no hydrolytic activity towards dietary fibers when in the active state.
- Glucose has 70-75% the sweetness of sucrose, whereas fructose is twice as sweet as sucrose.
- processes for the manufacture of fructose are of considerable value because the sweetness of the product may be significantly increased without the addition of an external sugar source (such as sucrose or artificial sweetening agents).
- a number of specific enzymes or enzyme mixtures may be used for production of the hydrolyzed whole grain composition according to the invention.
- the alpha- amylase may be selected from Validase HT 425L and Validase RA from Valley Research, Fungamyl from Novozymes and MATS from DSM, the protease may be selected from the group consisting of Alcalase, iZyme B and iZyme G
- the concentration of the enzymes according to the invention in the nutritional product may influence the organoleptic parameters of the nutritional product.
- concentration of enzymes may also be adjusted by changing parameters such as temperature and incubation time.
- the nutritional product comprises 0.0001 to 5% by weight of the total whole grain content in the nutritional product of at least one of:
- an alpha-amylase or fragment thereof which alpha-amylase or fragment thereof shows no hydrolytic activity towards dietary fibers when in the active state
- - an amyloglucosidase or fragment thereof which amyloglucosidase shows no hydrolytic activity towards dietary fibers when in the active state
- glucose isomerase or fragment thereof, which amyloglucosidase shows no hydrolytic activity towards dietary fibers when in the active state.
- the nutritional product comprises 0.001 to 3% of the alpha-amylase by weight of the total whole grain content in the nutritional product, such as 0.01-3%, such as 0.01-0.1%, such as 0.01-0.5%, such as 0.01- 0.1%, such as 0.03-0.1%, such as 0.04-0.1%.
- the nutritional product comprises 0.001 to 3% of the amyloglucosidase by weight of the total whole grain content in the nutritional product, such as 0.001-3%, such as 0.01-1%, such as 0.01-0.5%, such as 0.01-0.5%, such as 0.01-0.1%, such as 0.03-0.1%, such as 0.04-0.1%.
- the nutritional product comprises 0.001 to 3% of the glucose isomerase by weight of the total whole grain content in the nutritional product, such as 0.001-3%, such as 0.01- 1%, such as 0.01-0.5%, such as 0.01-0.5%, such as 0.01-0.1%, such as 0.03- 0.1%, such as 0.04-0.1%.
- Beta-amylases are enzymes which also break down saccharides, however beta- amylases mainly have maltose as the smallest generated carbohydrate entity.
- the nutritional product according to the invention does not comprise a beta-amylase, such as an exogenic beta-amylase.
- beta-amylases By avoiding beta-amylases a larger fraction of the starches will be hydrolyzed to glucose units since the alpha amylases do have to compete with the beta-amylases for substrates. Thus, an improved sugar profile may be obtained.
- US 5,686,123 discloses a cereal suspension generated by treatment with both an alpha-amylase and a beta-amylase.
- the action of the protease is not necessary, to provide a sufficient low viscosity.
- the nutritional product does not comprise the protease, such as an exogenic protease.
- protease such as an exogenic protease.
- the addition of protease may generate a bitter off-taste which in certain instances is desirable to avoid.
- US 4,282,319 discloses a process including enzymatic treatment with a protease and an amylase.
- the enzymes used according to the present invention for producing the hydrolyzed whole grain composition show no hydrolytic activity towards dietary fibers when in the active state.
- the hydrolyzed whole grain composition has a substantial intact beta-glucan structure relative to the starting material.
- the hydrolyzed whole composition has a substantial intact arabinoxylan structure relative to the starting material.
- substantially intact structure is to be understood that the structure is at least 95% intact, such as at least 97%, such as at least 98%, or such as at least 99% intact.
- enzymes such as proteases, amylases, glucose isomerases and amyloglucosidases refer to enzymes which have been previously purified or partly purified. Such proteins/enzymes may be produced in bacteria, fungi or yeast, however they may also have plant origin. In general such produced enzymes will in the present context fall under the category "exogenic enzymes". Such enzymes may be added to a product during production to add a certain enzymatic effect to a substance. Similar, in the present context, when an enzyme is disclaimed from the present invention such disclaimer refers to exogenic enzymes. In the present context such enzymes e.g . provide enzymatic
- composition has a glucose content of at least 0.25% by weight of the hydrolysed whole grain composition, on a dry matter basis, such as at least 0.35%, e.g . at least 0.5%.
- the nutritional product has a maltose to glucose ratio below 144: 1, by weight in the product, such as below 120 : 1, such as below 100 : 1 e.g. below 50 : 1, such as below 30 : 1, such as below 20 : 1 or such as below 10 : 1.
- starch processing enzyme used is a glucose generating alpha-amylase
- a larger fraction of the end product will be in the form of glucose compared to the use of an alpha-amylase specifically generating maltose units. Since glucose has a higher sweetness than maltose, this may result in that the addition of a further sugar source (e.g. sucrose) can be dispensed. This advantage may be further pronounced if the ratio is lowered by the conversion of the maltose present in the hydrolyzed whole grain to glucose (one maltose unit is converted to two glucose units).
- the maltose to glucose ratio may be further lowered if an amyloglucosidase is included in the enzyme composition since such enzymes also generates glucose units.
- the nutritional product has a maltose to glucose + fructose ratio below 144: 1 by weight in the product, such as below 120 : 1, such as below 100 : 1 e.g. below 50 : 1, such as below 30 : 1, such as below 20 : 1 or such as below 10 : 1.
- the nutritional product may have a maltose to fructose ratio below 230: 1 by weight in the product, such as below 144: 1, such as below 120 : 1, such as below 100 : 1 e.g . below 50 : 1, such as below 30: 1, such as below 20 : 1 or such as below 10 : 1.
- total content of the whole grain is to be understood as the combination of the content of “hydrolyzed whole grain composition” and “solid whole grain content”. If not indicated otherwise, “total content of the whole grain” is provided as % by weight in the final product.
- the nutritional product has a total content of the whole grain in the range of 1-30% by weight of the nutritional product, such as 1-20%, such as 1- 15%, such as 1-10%, and such as 1-7%.
- the phrasing "content of the hydrolyzed whole grain composition” is to be understood as the % by weight of hydrolyzed whole grains in the final product. Hydrolyzed whole grain composition content is part of the total content of the whole grain composition.
- the nutritional product according to the invention has a content of the hydrolyzed whole grain composition in the range 1-30% by weight of the nutritional product, such as 1-20%, such as 1-10% and such as 1-5%.
- the amount of the hydrolyzed whole grain composition in the final product may depend on the type of product.
- a higher amount of hydrolyzed whole grains may be added (compared to a non-hydrolyzed whole grain composition) without substantially affecting the organoleptic parameters of the product because of the increased amount of soluble fibers in the hydrolysed whole grain.
- the nutritional product has a content of dietary fibers in the range of 0.1-10% by weight of the nutritional product, preferably, in the range of 0.5-3%, even more preferably in the range of 1-2% (w/w).
- a nutritional product according to the invention may be provided with high amounts of dietary fibers by the addition of the hydrolyzed whole grain
- Dietary fibers are the edible parts of plants that are not broken down by digestion enzymes. Dietary fibers are fermented in the human large intestine by the microflora. There are two types of fibers: soluble fibers and insoluble fibers. Both soluble and insoluble dietary fibers can promote a number of positive physiological effects, including a good transit through the intestinal tract which helps to prevent constipation, or a feeling of fullness. Health authorities recommend a consumption of between 20 and 35 g per day of fibers, depending on the weight, gender, age and energy intake.
- Soluble fibers are dietary fibers that undergo complete or partial fermentation in the large intestine.
- Examples of soluble fibers from cereals include beta-glucans, arabinoxylans, arabinogalactans and resistant starch type 2 and 3, and
- Soluble fibers from other sources include pectins, acacia gum, gums, alginate, agar, polydextrose, inulins and galacto-oligosaccharides for instance.
- Some soluble fibers are called prebiotics, because they are a source of energy for the beneficial bacteria (e.g. Bifidobacteria and Lactobacilli) present in the large intestine.
- Further benefits of soluble fibers include blood sugar control, which is important in diabetes prevention, control of cholesterol, or risk reduction of cardiovascular disease.
- Insoluble fibers are the dietary fibers that are not fermented in the large intestine or only slowly digested by the intestinal microflora.
- insoluble fibers examples include celluloses, hemicelluloses, resistant starch type 1 and lignins. Further benefits of insoluble fibers include promotion of the bowel function through stimulation of the peristalsis, which causes the muscles of the colon to work more, become stronger and function better. There is also evidence that consumption of insoluble fibers may be linked to a reduced risk of gut cancer.
- the total solid content of the nutritional product according to the invention may vary.
- the total solid content is in the range of 1- 50% by weight of the nutritional product, e.g. less than 50, such as less than 40%, such as less than 25% or such as less than 10%.
- factors influencing the solid content may be the amount of the hydrolyzed whole grain composition and the degree of hydrolysis in this composition.
- total solid content equals 100 minus moisture content (%) of the product.
- the nutritional product has a content of sugar or a non-sugar sweetener of less than 12% by weight of the nutritional product, such as less than 10%, less than 7%, less than 5%, less than 3%, less than 1% or such as 0%. Since the hydrolyzed whole grain composition supplements the nutritional product with a source of carbohydrates, such as glucose and maltose, the nutritional product is also sweetened from a natural sugar source different from the external sugar source. Thus, the amount of added external sweetener may be limited. Sucrose is a widely used sweetener in food products, however others sugars may also be used.
- the sugar is a monosaccharide and/or a disaccharide and/or an oligosaccharide.
- the monosaccharide is glucose, galactose, dextrose, fructose or any combination thereof.
- the disaccharide is sucrose, maltose, lactose or any combination thereof.
- the water activity of the nutritional products may vary.
- the nutritional product has a water activity above 0.35, such as above 0.5, such as above 0.7, or such as above 0.8. Since water activity reflects water content it often also reflects the viscosity of the products. Thus, an increased water activity may result in a lowered viscosity.
- Water activity or a w is a measurement of water content. It is defined as the vapor pressure of a liquid divided by that of pure water at the same temperature; therefore, pure distilled water has a water activity of exactly one. As the temperature increases a w typically increases, except in some products with crystalline salt or sugar. At a w -values above 0.65 crunchy products traditionally looses crunchyness.
- Humectants are often added to products which are to be in a dry or semi-dry state.
- the nutritional product does not comprise a humectant.
- Supplementary ingredients of the nutritional product include, preservatives such as tocopherol, and emulsifiers, such as lecithin, protein powders, cocoa solid, alkylresorcinols, phenolics and other active ingredients, such as DHA, caffeine, and prebiotics.
- the nutritional product has a fat content in the range 1- 60%, such as in the range 5-50%, such as in the range 5-40%, such as in the range 5-30%, by weight of the nutritional product. .
- the amount of fat may vary depending on the type of product.
- Fat components are preferably vegetable fats such as cocoa butter, rapeseed oil, sunflower oil or palm oil, preferably not hydrogenated.
- the nutritional product may have salt content in the range 0-2% by weight of the nutritional product.
- the salt is sodium chloride.
- flavor component is selected from the group consisting butterscotch, vanilla, cocoa, coffee, fruit, malt, soya, tea, vegetable, and combinations thereof.
- the nutritional product according to the invention may be supplemented with a liquid component to provide the right consistency and viscosity.
- the nutritional product further comprises a liquid component.
- the liquid component is selected from the group consisting of water, milk, liquid fruit extract, liquid vegetable extracts, liquid coffee extract, liquid chocolate extract, tea concentrate, malt extract, plant extracts, a soya component or any combination hereof.
- the milk is selected from the group consisting of whole milk, cream, 2% fat milk, 1% fat milk, non-fat skim milk, non-dairy creamer, whey fractions, casein, and any combination hereof. Addition of a liquid component may improve factors such as taste, viscosity and the nutritional profile.
- a process for preparing a nutritional product comprising : 1) preparing a hydrolyzed whole grain composition, comprising the steps of: a) contacting a whole grain component with an enzyme composition in water, the enzyme composition comprising at least one alpha-amylase, said enzyme composition showing no hydrolytic activity towards dietary fibers, b) allowing the enzyme composition to react with the whole grain
- composition with at least 2 essential minerals and at least 4 essential vitamins.
- the enzyme composition further comprises a protease or fragment thereof, which protease or fragment thereof shows no hydrolytic activity towards dietary fibers when in the active state.
- the enzyme composition may comprise an amyloglucosidase and/or and glucose isomerase according to the present invention .
- step lb) is performed at 30-100°C, preferably 50 to 85°C.
- step lb) is performed for 1 minute to 24 hours, such as 1 minute to 12 hours, such as 1 minute to 6 hours, such as 5-120 minutes.
- step lb) is performed at 30-100°C for 5-120 minutes.
- step lc) is allowed to proceed at 70-150°C for at least 1 second, such as 1-5 minutes, such as 5-120 minutes, such as 5-60 minutes. In an additional embodiment step lc) is performed by heating to at least 90°C for 5-30 minutes.
- the reaction in step lc) is stopped when the hydrolysate has reached a viscosity comprised between 50 and 4000 mPa.s, such as between 50 and 3000 mPa .s, such as between 50 and 1000 mPa .s, such as between 50 and 500 mPa.s. In an additional embodiment viscosity is measured at TS 50.
- the hydrolyzed whole grain composition in step 1) is provided when said hydrolysate has reached a total solid content of 25-60%.
- the hydrolyzed whole grain may be provided in different forms.
- the hydrolyzed whole grain component in step lc) is provided in the form of a liquid, a concentrate, a powder, a juice or a pure.
- An advantage of having hydrolyzed whole grain composition in different forms is that when used in a food product dilution may be avoided by using a dry or semi dry form. Similarly, if a more moisten product is desirable, a hydrolyzed whole grain composition in a liquid state may be used.
- the above parameters can be adjusted to regulate the degree of starch degradation, the sugar profile, the total solid content and to regulate the overall organoleptic parameters of the final product.
- the grains may be advantageous to process the grains before or after the enzymatic treatment.
- grounding the grains a larger surface area is made accessible to the enzymes, thereby speeding up the process.
- organoleptic parameters may be improved by using a smaller particle size of the grains.
- the whole grains are roasted or toasted before or after enzymatic treatment. Roasting and toasting may improve the taste of the final product.
- the process further comprises at least one of the following treatments: UHT, pasteurization, thermal treatment, retort and any other thermal or non-thermal treatments, such as pressure treatment.
- the nutritional product is applied to an enclosure under aseptic conditions.
- the nutritional product is applied to an enclosure under non-aseptic conditions, such as by retort or hot-for-hold.
- Enzyme compositions comprising Validase HT 425L (alpha-amylase) optionally in combination with Alcalase 2.4 L (protease) were used for the hydrolysis of wheat, barley and oats.
- Mixing may be performed in a double jacket cooker, though other industrial equipment may be used.
- a scraping mixer works continuously and scraps the inner surface of the mixer. It avoids product burning and helps maintaining a homogeneous temperature. Thus enzyme activity is better controlled .
- Steam may be injected in the double jacket to increase temperature while cold water is used to decrease it.
- the enzyme composition and water are mixed together at room temperature, between 10 and 25°C. At this low temperature, the enzymes of the enzyme composition have a very weak activity.
- the whole grain component is then added and the ingredients are mixed for a short period of time, usually less than 20 minutes, until the mixture is homogeneous. The mixture is heated progressively or by thresholds to activate the enzymes and hydrolyse the whole grain component.
- Hydrolysis results in a reduction of the viscosity of the mixture.
- the enzymes are inactivated by heating the hydrolysate at a temperature above 100°C, preferably by steam injection at 120°C.
- Enzymes are dosed according to the quantity of total whole grain. Quantities of enzymes are different depending on the type of whole grain component, as protein rates are different. The ratio water/whole grain component can be adapted according to required moisture for the final liquid whole grain. Usually, the water/whole grain component ratio is 60/40. Percents are by weight. Hydrolysed whole wheat
- Example 2 Sugar profile of the hydrolyzed whole grain composition
- the hydrolyzed whole grain compositions were analysed by HPAE for illustrating the sugar profile hydrolysed whole grain composition.
- Carbohydrates are extracted with water, and separated by ion chromatography on an anion exchange column.
- the eluted compounds are detected electrochemically by means of a pulsed amperometric detector and quantified by comparison with the peak areas of external standards.
- Duplicate samples (defatted if necessary) are digested for 16 hours in a manner that simulates the human digestive system with 3 enzymes (pancreatic alpha- amylase, protease, and amyloglucosidase) to remove starch and protein. Ethanol is added to precipitate high molecular weight soluble dietary fibre. The resulting mixture is filtered and the residue is dried and weighed. Protein is determined on the residue of one of the duplicates; ash on the other. The filtrate is captured, concentrated, and analyzed via HPLC to determine the value of low molecular weight soluble dietary fibre (LMWSF).
- LWSF low molecular weight soluble dietary fibre
- an increased sweetness may be obtained by using the hydroiyzed whole grain composition according to the invention and therefore the need for further sweetening sources may be dispensed or limited .
- the results demonstrate that the dietary fiber content is kept intact and the ratio and amount of soluble and insoluble fibers are substantially the same in the non-hydrolyzed whole grain and in the hydrolyzed whole grain composition.
- the enzymes Validase HT 425L (Valley Research), Alcalase 2.4L (Novozymes) and BAN (Novozymes) were analysed using a thin layer chromatography analysis for activity towards arabinoxylan and beta-glucan fibre extracts both components of dietary fibers of whole grain.
- the results from the thin layer chromatography analysis showed that the amylase Validase HT and the protease Alcalase showed no hydrolytic activity on either beta-glucan or arabinoxylan, while the commercial alpha-amylase preparation, BAN, causes hydrolysis of both the beta-glucan and arabinoxylan, see figure 1. See also example 4.
- the enzyme was added at an enzyme to substrate ratio (E/S) of 0.1 % (v/v). The reaction was allowed to proceed at 50°C for 20 minutes, the sample was then placed at 85°C during 15 min to enable starch gelatinization and hydrolysis. The enzymes were finally inactivated at 95°C for 15 minutes. Different batches of the following enzymes have been evaluated.
- Sodium Nitrate 0.1M/ at 0.5ml/min was used as running buffer. Detection was done by reflective index measurement.
- Example 5 Nutritional ready to drink beverage comprising a hydrolyzed whole grain composition.
- HWGC hydrolyzed whole grain composition
- Example 6 Nutritional powder comprising a hydrolyzed whole grain composition.
- HWGC hydrolyzed whole grain composition
- the powder is to be reconstituted in a liquid before consumption.
- Example 7 Nutritional tube feed comprising a hydrolyzed whole grain composition.
- HWGC hydrolyzed whole grain composition
- Example 8 RTD Complete Nutrition Product for Weight Loss comprising a hydrolyzed whole grain composition.
- HWGC hydrolyzed whole grain composition
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychiatry (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cereal-Derived Products (AREA)
- Grain Derivatives (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2010329967A AU2010329967A1 (en) | 2009-12-09 | 2010-12-08 | Nutritional products comprising hydrolyzed whole grain |
US13/514,377 US20130136824A1 (en) | 2009-12-09 | 2010-12-08 | Nutritional products comprising hydrolyzed whole grain |
IN4454DEN2012 IN2012DN04454A (fr) | 2009-12-09 | 2010-12-08 | |
CN2010800558520A CN102651975A (zh) | 2009-12-09 | 2010-12-08 | 包含水解全谷粒的营养产品 |
CA2782884A CA2782884A1 (fr) | 2009-12-09 | 2010-12-08 | Produits nutritionnels comprenant des cereales entieres hydrolysees |
JP2012542535A JP2013513368A (ja) | 2009-12-09 | 2010-12-08 | 加水分解した全粒を含む栄養製品 |
EP10793206A EP2509440A1 (fr) | 2009-12-09 | 2010-12-08 | Produits nutritionnels comprenant des céréales entières hydrolysées |
RU2012128533/13A RU2012128533A (ru) | 2009-12-09 | 2010-12-08 | Продукты питания, содержащие гидролизованное цельное зерно злаков |
BR112012013979A BR112012013979A2 (pt) | 2009-12-09 | 2010-12-08 | produtos nutricionais compreendendo grão integral hidrolisado |
MX2012006343A MX2012006343A (es) | 2009-12-09 | 2010-12-08 | Productos nutricionales que comprenden cereal integral hidrolizado. |
ZA2012/05064A ZA201205064B (en) | 2009-12-09 | 2012-07-06 | Nutritional products comprising hydrolyzed whole grain |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09178491.8 | 2009-12-09 | ||
EP09178491A EP2335499A1 (fr) | 2009-12-09 | 2009-12-09 | Procédé de fabrication de barre de céréales entières et barre de céréales |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011070057A1 true WO2011070057A1 (fr) | 2011-06-16 |
Family
ID=42097313
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2010/069147 WO2011070057A1 (fr) | 2009-12-09 | 2010-12-08 | Produits nutritionnels comprenant des céréales entières hydrolysées |
PCT/EP2010/069209 WO2011070086A1 (fr) | 2009-12-09 | 2010-12-08 | Produits alimentaires et enrobages pour ceux-ci comprenant des céréales entières hydrolysées |
PCT/EP2010/069205 WO2011070085A1 (fr) | 2009-12-09 | 2010-12-08 | Composition de céréales entières hydrolysées |
PCT/EP2010/069203 WO2011070083A1 (fr) | 2009-12-09 | 2010-12-08 | Procédé pour fabriquer une barre de céréales entières et barre de céréales |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2010/069209 WO2011070086A1 (fr) | 2009-12-09 | 2010-12-08 | Produits alimentaires et enrobages pour ceux-ci comprenant des céréales entières hydrolysées |
PCT/EP2010/069205 WO2011070085A1 (fr) | 2009-12-09 | 2010-12-08 | Composition de céréales entières hydrolysées |
PCT/EP2010/069203 WO2011070083A1 (fr) | 2009-12-09 | 2010-12-08 | Procédé pour fabriquer une barre de céréales entières et barre de céréales |
Country Status (19)
Country | Link |
---|---|
US (3) | US20130136824A1 (fr) |
EP (5) | EP2335499A1 (fr) |
JP (1) | JP2013513368A (fr) |
KR (1) | KR20120123307A (fr) |
CN (3) | CN102740709A (fr) |
AU (3) | AU2010329967A1 (fr) |
BR (3) | BR112012013922A2 (fr) |
CA (2) | CA2782884A1 (fr) |
CL (1) | CL2012001546A1 (fr) |
CO (1) | CO6541634A2 (fr) |
EC (1) | ECSP12011963A (fr) |
IL (2) | IL220177A (fr) |
IN (3) | IN2012DN04454A (fr) |
MX (3) | MX2012006551A (fr) |
PE (1) | PE20130328A1 (fr) |
RU (3) | RU2567206C2 (fr) |
SG (1) | SG181163A1 (fr) |
WO (4) | WO2011070057A1 (fr) |
ZA (1) | ZA201205064B (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012076058A1 (fr) * | 2010-12-08 | 2012-06-14 | Nestec S.A. | Composition de remplissage comprenant des céréales complètes hydrolysées |
WO2021099457A1 (fr) | 2019-11-22 | 2021-05-27 | Novozymes A/S | Procédé d'obtention d'un produit à base d'avoine |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012076056A1 (fr) * | 2010-12-08 | 2012-06-14 | Nestec S.A. | Produit alimentaire comprenant une céréale entière hydrolysée |
CN104187624B (zh) * | 2014-08-07 | 2016-06-08 | 逯明福 | 综合营养粉及其制备方法 |
US9826775B2 (en) | 2015-01-08 | 2017-11-28 | Brian B. Park | Food forming and shaping device |
US20190166890A1 (en) * | 2016-07-15 | 2019-06-06 | Nestec S.A. | Process for preparing hydrolysed starch with reduced sugar content |
BR122022025211B1 (pt) * | 2017-05-05 | 2023-09-26 | Société Des Produits Nestlé S.A | Fração pré-reagida e processo de preparação da mesma |
CN107279891A (zh) * | 2017-08-02 | 2017-10-24 | 集美大学 | 一种营养型大米果冻及其制备方法 |
CN111447841A (zh) * | 2017-12-15 | 2020-07-24 | 雀巢产品有限公司 | 用于糖调节的方法 |
CN109953276B (zh) * | 2017-12-25 | 2023-04-07 | 丰益(上海)生物技术研发中心有限公司 | 慢消化谷物食品及其制备方法 |
KR102244586B1 (ko) * | 2018-11-30 | 2021-04-26 | 주식회사 남도농산 | 귀리분말 제조방법 |
KR20240057477A (ko) | 2022-10-24 | 2024-05-03 | 주식회사 하모니팜 | 레토르트 완숙 곡물 식품 및 그 제조 방법 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2406665A1 (fr) * | 1977-10-18 | 1979-05-18 | Lyckeby Staerkelsefoeraedling | Procede de preparation d'un produit hydrolyse a partir de cereales completes et produit ainsi obtenu |
US4894242A (en) * | 1986-04-24 | 1990-01-16 | Mitchell Cheryl R | Nutritional rice milk product |
US5686123A (en) | 1993-09-15 | 1997-11-11 | Lindahl; Lennart | Homogeneous and stable cereal suspension and a method of making the same |
EP1371295A2 (fr) * | 2002-06-12 | 2003-12-17 | Ezio Bartocci | Alimentation à base de riz et procédé pour sa préparation |
US20070014892A1 (en) * | 2005-07-15 | 2007-01-18 | Mitchell Cheryl R | Whole grain non-dairy milk production, products and use |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE871364A (fr) * | 1977-10-18 | 1979-02-15 | Lyckeby Staerkelsefoeraedling | Procede de preparation d'un produit d'hydrolyse de grain complet et produit ainsi obtenu |
FR2539587A1 (fr) * | 1983-01-20 | 1984-07-27 | Gen Foods Corp | Procede de preparation de cereales saccharifiees par les enzymes provenant de grains de cereales entiers et cereales obtenues par ce procede |
US4656040A (en) * | 1983-03-31 | 1987-04-07 | General Foods Corporation | Process for preparing an all grain, enzyme-saccharified cereal and product produced |
JPS60149351A (ja) * | 1984-01-10 | 1985-08-06 | Nisshin Flour Milling Co Ltd | 胚芽成分の抽出方法 |
US4710386A (en) * | 1985-01-29 | 1987-12-01 | General Foods Corporation | All natural, ready-to-eat enzyme-saccharified cereal derived from whole cereal grain |
SE8505783D0 (sv) * | 1985-12-06 | 1985-12-06 | Rolf Bergkvist | Forfarande for framstellning av livsmedelsprodukter och dessas anvendning |
US4857339A (en) * | 1987-09-28 | 1989-08-15 | Nabisco/Cetus Food Biotechnology Research Partnership | Method for making cereal products naturally sweetened with fructose |
EP0312220A1 (fr) * | 1987-09-28 | 1989-04-19 | Nabisco/Cetus Food Biotechnology Research Partnership | Produits de céréales édulcorés naturellement avec du fructose |
US4871557A (en) * | 1988-06-15 | 1989-10-03 | Amway Corporation | Granola bar with supplemental dietary fiber and method |
US6685974B2 (en) * | 1995-01-26 | 2004-02-03 | American Oats, Inc. | Process for preparing an oat-based functional syrup |
JPH09299046A (ja) * | 1996-05-17 | 1997-11-25 | Nof Corp | 栄養素強化流動食 |
US6007851A (en) * | 1996-12-23 | 1999-12-28 | Gist-Brocades, B.V. | Process for producing a flavor enhancer |
JP4074901B2 (ja) * | 1997-02-14 | 2008-04-16 | 日清フーズ株式会社 | 植物胚芽から得られる亜鉛高含量成分およびその製造法 |
AU1736200A (en) * | 1998-11-20 | 2000-06-13 | Kellogg Company | Enzymatic preparation of cereal base |
US6482942B1 (en) * | 1999-01-12 | 2002-11-19 | Biotechnology Services And Consulting, Inc. | Method of isolating mucilaginous polysaccharides and uses thereof |
SE517598C2 (sv) * | 2000-02-23 | 2002-06-25 | Ingemar Bjurenwall | Förfarnade för framställning av en sädesprodukt med förstärkt proteininnehåll och förbättrad bakegenskaper samt sädesprodukt framställd genom detta förfarande |
JP2002012547A (ja) * | 2000-06-28 | 2002-01-15 | Ito En Ltd | 糖質分解阻害剤、インスリン分泌抑制剤及び健康飲食物 |
JP2002233300A (ja) * | 2001-02-09 | 2002-08-20 | Hyozo Konno | 米粉を主原料とするパン様食品の製造方法 |
CA2437931C (fr) | 2001-02-19 | 2011-11-01 | Societe Des Produits Nestle S.A. | Produit consommable contenant des probiotiques |
US20040258829A1 (en) * | 2003-04-02 | 2004-12-23 | Guo-Hua Zheng | Dietary fiber containing materials comprising low molecular weight glucan |
FI20031004A0 (fi) * | 2003-07-03 | 2003-07-03 | Raisio Benecol Oy | Uusi syötävä koostumus |
US7794774B2 (en) * | 2005-11-07 | 2010-09-14 | The Quaker Oats Company | Long shelf-life high moisture content cereal products |
US7629008B2 (en) * | 2005-11-07 | 2009-12-08 | Kraft Foods Global Brands Llc | Low-calorie whole grain cereal bar |
US8993039B2 (en) * | 2006-01-25 | 2015-03-31 | Tate & Lyle Ingredients Americas Llc | Fiber-containing carbohydrate composition |
CA2697673C (fr) * | 2007-08-29 | 2017-01-03 | Sapporo Breweries Limited | Procede de production de sirop d'orge |
WO2009077457A1 (fr) * | 2007-12-14 | 2009-06-25 | Nestec S.A. | Protéine de céréale hypoallergénique et ses utilisations |
JP5074238B2 (ja) * | 2008-02-29 | 2012-11-14 | マルサンアイ株式会社 | 穀物原液の連続製造法、穀物原液及びその連続製造装置 |
CN101258880B (zh) * | 2008-04-25 | 2011-04-06 | 内蒙古蒙牛乳业(集团)股份有限公司 | 乳制品生产方法 |
FI121844B (fi) * | 2008-09-01 | 2011-05-13 | Ravintoraisio Oy | Parannettu syötävä koostumus ja menetelmä sen valmistamiseksi |
SE534934C2 (sv) * | 2009-06-01 | 2012-02-21 | Biovelop Ab | Cerealieprodukt av havre samt metod för att tillverka densamma |
-
2009
- 2009-12-09 EP EP09178491A patent/EP2335499A1/fr not_active Withdrawn
-
2010
- 2010-12-08 RU RU2012128537/13A patent/RU2567206C2/ru not_active IP Right Cessation
- 2010-12-08 JP JP2012542535A patent/JP2013513368A/ja active Pending
- 2010-12-08 EP EP10787479A patent/EP2509437A1/fr not_active Withdrawn
- 2010-12-08 EP EP10793206A patent/EP2509440A1/fr not_active Withdrawn
- 2010-12-08 AU AU2010329967A patent/AU2010329967A1/en not_active Abandoned
- 2010-12-08 RU RU2012128550/13A patent/RU2012128550A/ru not_active Application Discontinuation
- 2010-12-08 RU RU2012128533/13A patent/RU2012128533A/ru not_active Application Discontinuation
- 2010-12-08 BR BR112012013922A patent/BR112012013922A2/pt not_active Application Discontinuation
- 2010-12-08 CN CN2010800633748A patent/CN102740709A/zh active Pending
- 2010-12-08 WO PCT/EP2010/069147 patent/WO2011070057A1/fr active Application Filing
- 2010-12-08 BR BRBR112012014064-7A patent/BR112012014064A2/pt not_active IP Right Cessation
- 2010-12-08 EP EP10787478A patent/EP2509446A1/fr not_active Withdrawn
- 2010-12-08 SG SG2012040770A patent/SG181163A1/en unknown
- 2010-12-08 CN CN2010800633682A patent/CN102740708A/zh active Pending
- 2010-12-08 US US13/514,377 patent/US20130136824A1/en not_active Abandoned
- 2010-12-08 MX MX2012006551A patent/MX2012006551A/es not_active Application Discontinuation
- 2010-12-08 BR BR112012013979A patent/BR112012013979A2/pt not_active Application Discontinuation
- 2010-12-08 EP EP10790550A patent/EP2509438A1/fr not_active Withdrawn
- 2010-12-08 WO PCT/EP2010/069209 patent/WO2011070086A1/fr active Application Filing
- 2010-12-08 MX MX2012006641A patent/MX2012006641A/es not_active Application Discontinuation
- 2010-12-08 US US13/514,520 patent/US20120269928A1/en not_active Abandoned
- 2010-12-08 KR KR1020127017786A patent/KR20120123307A/ko not_active Application Discontinuation
- 2010-12-08 US US13/514,518 patent/US20120244253A1/en not_active Abandoned
- 2010-12-08 IN IN4454DEN2012 patent/IN2012DN04454A/en unknown
- 2010-12-08 AU AU2010329902A patent/AU2010329902A1/en not_active Abandoned
- 2010-12-08 IN IN5020DEN2012 patent/IN2012DN05020A/en unknown
- 2010-12-08 WO PCT/EP2010/069205 patent/WO2011070085A1/fr active Application Filing
- 2010-12-08 IN IN5019DEN2012 patent/IN2012DN05019A/en unknown
- 2010-12-08 MX MX2012006343A patent/MX2012006343A/es not_active Application Discontinuation
- 2010-12-08 CA CA2782884A patent/CA2782884A1/fr not_active Abandoned
- 2010-12-08 CA CA2783397A patent/CA2783397A1/fr not_active Abandoned
- 2010-12-08 WO PCT/EP2010/069203 patent/WO2011070083A1/fr active Application Filing
- 2010-12-08 PE PE2012000805A patent/PE20130328A1/es unknown
- 2010-12-08 CN CN2010800558520A patent/CN102651975A/zh active Pending
- 2010-12-08 AU AU2010329901A patent/AU2010329901A1/en not_active Abandoned
-
2012
- 2012-06-05 IL IL220177A patent/IL220177A/en not_active IP Right Cessation
- 2012-06-05 IL IL220178A patent/IL220178A/en active IP Right Grant
- 2012-06-08 CL CL2012001546A patent/CL2012001546A1/es unknown
- 2012-06-08 EC ECSP12011963 patent/ECSP12011963A/es unknown
- 2012-06-12 CO CO12098481A patent/CO6541634A2/es not_active Application Discontinuation
- 2012-07-06 ZA ZA2012/05064A patent/ZA201205064B/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2406665A1 (fr) * | 1977-10-18 | 1979-05-18 | Lyckeby Staerkelsefoeraedling | Procede de preparation d'un produit hydrolyse a partir de cereales completes et produit ainsi obtenu |
US4282319A (en) | 1977-10-18 | 1981-08-04 | Kockums Construction Ab | Process for the preparation of a hydrolyzed product from whole grain |
US4894242A (en) * | 1986-04-24 | 1990-01-16 | Mitchell Cheryl R | Nutritional rice milk product |
US5686123A (en) | 1993-09-15 | 1997-11-11 | Lindahl; Lennart | Homogeneous and stable cereal suspension and a method of making the same |
EP1371295A2 (fr) * | 2002-06-12 | 2003-12-17 | Ezio Bartocci | Alimentation à base de riz et procédé pour sa préparation |
US20070014892A1 (en) * | 2005-07-15 | 2007-01-18 | Mitchell Cheryl R | Whole grain non-dairy milk production, products and use |
Non-Patent Citations (1)
Title |
---|
TOVE STENBERG; ROGER ANDERSSON; ANNICA ANDERSSON; PER ÂMAN.: "Determination of beta-Glucan Molecular Weight Using SEC with Calcofluor Detection in Cereal Extracts Lena Rimsten", CEREAL CHEM., vol. 80, no. 4, pages 485 - 490 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012076058A1 (fr) * | 2010-12-08 | 2012-06-14 | Nestec S.A. | Composition de remplissage comprenant des céréales complètes hydrolysées |
WO2021099457A1 (fr) | 2019-11-22 | 2021-05-27 | Novozymes A/S | Procédé d'obtention d'un produit à base d'avoine |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2648545B1 (fr) | Boissons prêtes à boire comprenant des céréales entières hydrolysées | |
US20130136824A1 (en) | Nutritional products comprising hydrolyzed whole grain | |
AU2011340589B2 (en) | Instant drink powders comprising hydrolyzed whole grain | |
US20130280378A1 (en) | Cereal milk drink comprising hydrolyzed whole grain for infants | |
EP2648546B1 (fr) | Sirop comprenant des céréales entières hydrolysées | |
EP2648532B1 (fr) | Produit composite comprenant une composition de remplissage comprenant des céréales complètes hydrolysées | |
EP2648542B1 (fr) | Produits à base de céréales pour bébé comprenant des céréales complètes hydrolysées | |
WO2012076054A1 (fr) | Produit alimentaire comprenant une céréale entière hydrolysée | |
AU2017245420A1 (en) | Filling composition comprising hydrolyzed whole grain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080055852.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10793206 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12012500980 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 4454/DELNP/2012 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012542535 Country of ref document: JP Ref document number: 2010329967 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/006343 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2782884 Country of ref document: CA |
|
REEP | Request for entry into the european phase |
Ref document number: 2010793206 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010793206 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1201002703 Country of ref document: TH |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2010329967 Country of ref document: AU Date of ref document: 20101208 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012128533 Country of ref document: RU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13514377 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012013979 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012013979 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120611 |